UTRECHT, THE NETHERLANDS, MARCH 29 2016 – U-PACT B.V., the platelet diagnostics company based in the Netherlands, announces that it has closed its biologicals license agreement with University Medical Center Utrecht (UMC Utrecht) for the exclusive rights on the proprietary biological reagents and methodology of the PACT assay.

U-PACT will use the biological reagents and methodology to develop and validate the PACT assay for commercial sale. U-PACT is a specialized platelet diagnostics company that develops, validates, manufactures and sells platelet diagnostic tools. For more information on U-PACT, please contact Dr. Martin Hessing (CEO): M.Hessing@U-PACT.com